In fact, Takahashi and co‐workers have recently reported that Bcl‐xL and Mcl‐1 might co‐operatively play a role in the apoptotic cell death of pancreatic cancer and that targeting both proteins may be a viable therapeutic strategy.33 This evidence concerns the gene MCL1 and familial pancreatic carcinoma.